Katie L. Waller

Also affiliated with Mayo Clinic in Arizona, Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma”.

Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0217

N/A

0DataRank · unranked

8 citations

Rachael A. Vaubel, Ju-Hee Oh, Ann C. Mladek, Surabhi Talele, Wenqiu Zhang +5 more

PK-PD-efficacy modeling of brigimadlin in MDM2-amplified glioblastoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2071

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Danielle M. Burgenske, Katie L. Waller, Paul A. Decker, Matt Kosel +13 more

Pre-clinical modeling of navtemadlin pharmacokinetics (PK), pharmacodynamics (PD), and efficacy in glioblastoma, IDH-wildtype.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2012

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Ann C. Mladek, Tugce I. Pasa, Katie L. Waller, Sylwia A. Stopka +15 more

Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0244

N/A

0DataRank · unranked

2 citations

Wenjuan Zhang, Ju-Hee Oh, Ann C. Mladek, Tugce I. Pasa, Jennifer Gantchev +24 more

Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf259

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Nishika Karbhari, Ju-Hee Oh, Katie L. Waller, Ann C. Mladek +16 more